Skip to main content
MF

MIM Fertility

MIM Fertility develops AI-powered tools, EMBRYOAID® and FOLLISCAN®, to enhance embryo assessment and ovarian follicular monitoring in IVF clinics. These solutions improve diagnostic accuracy and increase the likelihood of successful pregnancies by automating critical evaluation processes and providing precise measurements.

Arès, PolandFounded 2019202K+ followers
Updated 4 months ago

Funding

$2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

In vitro fertilization (IVF) success rates are affected by the accuracy and efficiency of embryo assessment and ovarian follicular monitoring. Manual evaluation methods are time-consuming, subjective, and can lead to variability in outcomes.

Solution

MIM Fertility offers two AI-powered solutions, EMBRYOAID® and FOLLISCAN®, designed to improve the precision and consistency of IVF procedures. EMBRYOAID® uses a single embryo image to automatically assess and grade a 5-day embryo's implantation potential, reflecting the embryologist workflow in a non-invasive manner. FOLLISCAN® accurately counts and measures follicles of all sizes in 2D or 3D cine-loops of the ovary, automating imaging ultrasonography to enhance diagnostic accuracy. These tools help fertility specialists make better-informed decisions, streamline clinical workflows, and ultimately improve patient outcomes by increasing the likelihood of successful pregnancies. MIM Fertility's solutions integrate seamlessly into existing EMR systems, providing scalability and reducing the workload for healthcare professionals.

Target Audience

MIM Fertility's primary customers are fertility specialists, embryologists, and IVF clinics seeking to enhance treatment efficacy, reduce costs, and improve success rates through AI-driven solutions.

Features

  • EMBRYOAID®: AI-driven assessment of 5-day embryo implantation potential from a single image
  • EMBRYOAID®: Non-invasive embryo evaluation with highly accurate and consistent outcomes
  • FOLLISCAN®: Automated follicle counting and measurement in 2D/3D ultrasound cine-loops
  • FOLLISCAN®: Achieves 97% accuracy in follicle measurement
  • EMR integration for both EMBRYOAID® and FOLLISCAN®
  • AI algorithms trained on extensive libraries of embryo images and time-lapse videos
  • Streamlines and standardizes IVF clinic workflows
  • Reduces time needed for embryo selection and ultrasound examinations
This profile is AI-generated and may contain inaccuracies.